T1	Participants 396 470	PATIENTS Sixty-two women with symptomatic uterine myomas (size 16-20 wks).
T2	Participants 539 756	MEASUREMENTS AND MAIN RESULTS Before surgery, women were assigned, at a ratio of 1:1 by random selection, to receive injections of triptorelin depot 11.25 mg 3 months before surgery (group A) or no treatment (group B)
